tradingkey.logo
tradingkey.logo
検索

Xtant Medical Holdings Inc

XTNT
ウォッチリストに追加
0.420USD
-0.001-0.24%
終値 07/01, 16:00ET15分遅れの株価
58.91M時価総額
31.91直近12ヶ月PER

詳細情報 Xtant Medical Holdings Inc 企業名

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Incの企業情報

企業コードXTNT
会社名Xtant Medical Holdings Inc
上場日Jun 30, 2010
最高経営責任者「CEO」Browne (Sean E)
従業員数217
証券種類Ordinary Share
決算期末Jun 30
本社所在地664 Cruiser Lane
都市BELGRADE
証券取引所NASDAQ OMX – NASDAQ Basic Amex
United States of America
郵便番号59714
電話番号14063880480
ウェブサイトhttps://xtantmedical.com/
企業コードXTNT
上場日Jun 30, 2010
最高経営責任者「CEO」Browne (Sean E)

Xtant Medical Holdings Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
--
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
--
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
+0.00%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

よくある質問

Xtant Medical Holdings Incの上位5名の株主は誰ですか?

Xtant Medical Holdings Incの上位5名の株主は以下のとおりです。Mr. Stavros G. Vizirgianakis

Xtant Medical Holdings Incの最大の収益源は何ですか?

2026Q4において、Orthobiologics部門がXtant Medical Holdings Incにとって最大の収益を生み出しており、その金額は72.89Mで、全収益の54.43%を占めています。